Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Calidi Biotherapeutics Inc 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 USA

https://calidibio.com Employees: 41 P: 858-794-9600

Description:

Calidi Biotherapeutics Inc. is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer with a novel stem cell-based therapy. Calidi Biotherapeutics Inc., formerly known as First Light Acquisition Group, is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 18,440
Enterprise Value, $K 18,550
Shares Outstanding, K 13,078
Annual Sales, $ 0 K
Annual Net Income, $ -29,220 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,070 K
EBIT, $ -39,520 K
EBITDA, $ -37,830 K
60-Month Beta 1.04
% of Insider Shareholders 24.28%
% of Institutional Shareholders 12.53%
Float, K 9,903
% Float 75.72%
Short Volume Ratio 0.35

Growth:

1-Year Return -91.32%
3-Year Return -98.57%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.65 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -4.05
EPS Growth vs. Prev Qtr 53.57%
EPS Growth vs. Prev Year 53.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/15/24

CLDI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -344.45%
Profit Margin % 0.00%
Debt/Equity -0.06
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.88
Interest Coverage -26.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar